Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire

Ophthalmic Epidemiology

Volumn 11, Issue 1, 2004, Pages 17-33

  Pitt, Andrew D ^a   Smith, Andrew F ^a,c   Lindsell, Lynda ^a   Voon, Li Wern ^a   Rose, Peter W ^b   Bron, Nthony J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Alcon Laboratories Ltd UK   (United Kingdom)

Author keywords

Health care costs; Pharmacotherapy; Quality of life; Seasonal allergic conjunctivitis

Indexed keywords

ALLERGEN;

ADOLESCENT; ADULT; AGE; AGED; ALLERGIC CONJUNCTIVITIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEMOGRAPHY; EYE INFLAMMATION; EYE PAIN; FEMALE; GENDER; HEALTH CARE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RHINOCONJUNCTIVITIS; SEASONAL VARIATION; STATISTICAL SIGNIFICANCE; UNITED KINGDOM; VISION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CONJUNCTIVITIS, ALLERGIC; COST OF ILLNESS; DRUG THERAPY; ENGLAND; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SEASONS;

EID: 1642356680     PISSN: 09286586     EISSN: None     Source Type: Journal    
DOI: 10.1076/opep.11.1.17.26437     Document Type: Article

References (20)

1. Leonardi A. Pathophysiology of allergic conjunctivitis. Acta Ophthalmol Scand. 1999;77:21-23.
2. Malone DC, Lawson KA, Smith DH, et al. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997;99:22-27.
3. Chapin MJ, George MA, Abelson MB. Olopatadine: Broadening choices for the treatment of allergic conjunctivitis. Todays Therapeutic Trends. 1999;17(1):67-84.
4. Dart JKG, Buckley RJ, Monnickendan M, Prasad J. Perennial allergic conjunctivitis: Definition, clinical characteristics and prevalence. Trans Ophthalmol Soc UK. 1986;105:513-520.
5. Anderson DF. Management of seasonal allergic conjunctivitis (SAC): current therapeutic strategies Clin Exp Allergy. 2001;31:823-826.
6. McMenamin P. Costs of hay fever in the United States in 1990. Ann Allergy. 1994;73:35-39.
7. Ray NF, Baraniuk JN, Thamer M, et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contribution of related airway illnesses. J Allergy Clin Immunol. 1999;103:401-407.
8. Lanier BQ, Gross RD, Marks B, et al. Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms. Ann Allergy Asthma Immunol. 2001;86(6):641-648.
9. Alexander M, Allegro S, Hicks A. Efficacy and acceptability of nedocromil sodium 2% and olopatadine hydrochloride 0.1% in perennial allergic conjunctivitis. Adv Ther. 2000;17(3):140-147.
10. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991;21:77-83.
11. Juniper EF. Rhinitis management: the patient's perspective. Clin Exp Allergy. 1998;28(Suppl 6):34-38.
12. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol. 1999;104:364-369.
13. nd December 2002.
14. nd December 2002.
15. nd December 2002.
16. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050-1058.
17. Mangione CM, Lee PP, Pitts J, et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116:1496-1504.
18. th September 2002.
19. The Gallup Organisation, Inc. Survey of attitudes and experiences of allergy persons with SAC. December 1989.
20. Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol. 1997;99:S773-780.